Oxymetholone (Anadrol)

Research records

Historical source snapshot. Not freshly verified, not a recommendation. Study findings, community accounts and app defaults are not interchangeable.

Publication suitability · 2026-10-15: Historical reference only; not a clinical verification. Clinical, regulatory, efficacy, safety and dose claims are not independently established by this review.

Oxymetholone (Anadrol)

An FDA-approved anabolic steroid used to treat anemias caused by deficient red-cell production.

Evidence category: Regulator / guideline. This describes the source category, not approval or certainty.

Regulatory statement in source: FDA-approved.

Oxymetholone is an FDA-approved anabolic steroid indicated for treating anemias caused by deficient red-cell production, including aplastic anemia, myelofibrosis, and anemia related to administration of myelotoxic drugs. It has been studied for HIV-associated wasting and other catabolic conditions with varying success.

Benefits reported in the imported source

• Anemias caused by deficient red-cell production, including aplastic anemia.

Risks and limits

• Significant hepatotoxicity (cholestatic jaundice is the most important hepatic side effect)
• Virilization in women
• Lipid abnormalities
• Cardiovascular effects

Source bottom line: FDA-approved for specific anemias; remains approved but hepatotoxicity is a major safety concern requiring monitoring.

Uncertainty: Reference information only. Not medical advice.

Study protocols — reports, not instructions

No study protocol recorded in this snapshot. This does not establish that no study exists.

Community and practice descriptions

Accounts of a practice are not evidence of safety or effectiveness. Words such as “standard”, “safe” or “recommended” describe the source account, not verified consensus or this wiki’s advice. Commercial and self-published citations are retained for traceability, not vendor endorsement or independent clinical corroboration.

No community description recorded. This entry has no final B-82 outcome record; it is not a researched-empty finding.

Pharmacokinetic context

No half-life recorded in this source snapshot. No value has been inferred.

Source references

• ANADROL-50 (oxymetholone) Label - FDA
• Review of Oxymetholone - PubMed